NCT00904215 - An Observational Study to Investigate the Efficacy, Safety, Tolerability and the Effect on Quality of Life of Telmisartan (Micardis) and Telmisartan With HCTZ (Micardis Plus) in Patients With Hypertension | Biotech Hunter

Enrollment

1,095

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

May 31, 2007

Conditions

Hypertension

Interventions

DRUG

telmisartan/telmisartan + HCTZ (Hydrochlorothiazide)

Trial Locations (11)

Boehringer ingelheim Investigational Site 1, Daegu

Boehringer ingelheim Investigational Site 4, Daegu

Boehringer ingelheim Investigational Site 7, Daegu

Boehringer ingelheim Investigational Site 9, Daejeon

Boehringer ingelheim Investigational Site 10, Koyang

Boehringer ingelheim Investigational Site 11, Kwangju

Boehringer ingelheim Investigational Site 3, Kwangju

Boehringer ingelheim Investigational Site 5, Pusan

Boehringer ingelheim Investigational Site 2, Seoul

Boehringer ingelheim Investigational Site 6, Suwon

Boehringer ingelheim Investigational Site 8, Wŏnju